Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
28.96
-0.05 (-0.17%)
Aug 12, 2025, 3:07 PM CST
-0.17%
Market Cap48.31B
Revenue (ttm)12.70B
Net Income (ttm)1.87B
Shares Out1.77B
EPS (ttm)1.06
PE Ratio27.44
Forward PE26.57
Dividend0.20 (0.69%)
Ex-Dividend DateJul 4, 2025
Volume37,459,449
Average Volume56,335,425
Open28.80
Previous Close29.01
Day's Range28.50 - 29.15
52-Week Range18.42 - 36.42
Beta0.93
RSI55.12
Earnings DateAug 22, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21,370
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial Statements

News

There is no news available yet.